Mizagliflozin
Sponsors
Vogenx, Inc.
Conditions
Postbariatric Hypoglycemia
Phase 2
Effect of Mizagliflozin on Postprandial Glucose and Insulin in Post-Bariatric Hypoglycemia Subjects
CompletedNCT05541939
Start: 2022-09-13End: 2023-02-17Updated: 2024-06-25
Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions
CompletedNCT05721729
Start: 2023-06-23End: 2025-06-01Updated: 2025-12-18